Outpatient Use of Ivermectin in COVID-19

NCT04530474 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped WHO report

Conditions

Covid19

Interventions

DRUG: Ivermectin Pill
DRUG: Placebo

Sponsor

Temple University